000 01469 a2200385 4500
005 20250514225809.0
264 0 _c20050901
008 200509s 0 0 eng d
022 _a1533-0346
024 7 _a10.1177/153303460500400303
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuarles, Christopher C
245 0 0 _aDexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.
_h[electronic resource]
260 _bTechnology in cancer research & treatment
_cJun 2005
300 _a245-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aBrain Neoplasms
_xblood supply
650 0 4 _aCerebrovascular Circulation
_xdrug effects
650 0 4 _aContrast Media
650 0 4 _aDexamethasone
_xtherapeutic use
650 0 4 _aGliosarcoma
_xblood supply
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aPerfusion
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aRegional Blood Flow
700 1 _aKrouwer, Hendrikus G J
700 1 _aRand, Scott D
700 1 _aSchmainda, Kathleen M
773 0 _tTechnology in cancer research & treatment
_gvol. 4
_gno. 3
_gp. 245-9
856 4 0 _uhttps://doi.org/10.1177/153303460500400303
_zAvailable from publisher's website
999 _c15558517
_d15558517